Archive for the ‘Drug Related’ Category

Accutane Lawsuit

Accutane (Isotretinoin) is an acne drug used to treat sever acne and it has been linked with side effects including inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis caused as a result of using the medication. The lawsuit claims that the drug manufacturer failed to warn doctors and patients about these serious side effects of the drug. Patients suffering from these side effects may be due a monitory settlement.

Ulcerative colitis affects the colon/rectum and causes inflammation of the digestive tract. This results in diarrhea and abdominal pain. Other symptoms include bloody diarrhea, weight loss, abdominal cramping and pain, and night sweats. Fulminant colitis is a rare version of ulcerative colitis – and can cause serious complications such as toxic megacolon and colon rupture.

Crohn’s disease typically affects the intestines and symptoms include abdominal pain, diarrhea, rectal bleeding and constipation.

If you are a loved one has taken Accutane and developed Crohn’s disease, inflammatory bowel disease or ulcerative colitis you may be able to participate in an Accutane lawsuit.

Kim, Khloe and Kourtney Kardashian QuickTrim Class Action Lawsuit

The Kardashian sisters – Kim, Khloe and Kourtney stars of the reality TV show “Keeping Up With the Kardashians” are faced with a $5 million class action lawsuit for their involvement with QuickTrim – an alleged weight loss product.

The defendants are alleged to have marketed QuickTrim stating that it increases metabolism, curbs appetite, and promotes weight loss.

The Manhattan federal court states that QuickTrim’s main ingredient is caffeine, which the FDA has determined is not a safe or effective treatment for weight control.  This has reportedly upset QuickTrim consumers some of whom state the use of false advertising.  Photos of the Kardashian sisters in revealing outfits is also alleged to be misleading.  Kim and Khloe have both tweeted that they have experienced 15 pound weight loss attributable to QuickTrim.  Legal experts argue this is false advertising.

 

Actos Lawsuits

The drug Actos (Pioglitazone) is prescribed to people with type 2 diabetes.  Its used to control blood sugar levels in conjunction with exercise and diet.  It increases how insulin is used by the body.  The drug is normally taken once daily.  It does not cure the type 2 diabetes.

It has been discovered that there are indications that the drug has serious side effects.  These include heart related issues such as congestive heart disease and bladder cancer.

The list of side effects includes bladder cancer, bone damage, liver damage, kidney damage, heart failure, heart attacks and other heart disease.

If you have been taking Actos and have developed symptoms of these diseases such as unexpected weight gain, shortness of breath, a slow heart rate or bladder problems then contact your doctor immediately.  You may also wish to seek legal help

Zoloft Heart Birth Defect Lawsuits

Zoloft  the antidepressant has been hit by lawsuits alleging that the drug has affected women who took the medicine while pregnant and has resulted in babies being born with heart birth defects.   The lawsuits state that the manufacturer of Zoloft knew that there were risks associated with taking the drug during pregnancy and that adequate warning was not issued to patients and doctors.

Zoloft Antidepressant Medication

The latest lawsuit states that the drug caused a baby to be born with a congenital birth defect and that Pfizer did not warn patients using the drug of the risks and that they concealed and suppressed information about Zoloft use while pregnant.

Zoloft is a Selective Serotonin Reuptake Inhibitors (SSRIs) and that these types of antidepressants had been introduced while they were linked to an increased risk of certain congenital defects including Persistent Pulmonary Hypertension and other heart defects.

Originally the  US Food and Drug Administration (FDA) had issued a warning that SSRIs stating that the drug could possibly cause an increased risk of pulmonary hypertension of the newborn. This was retracted during December of 2011 stating that links between use while pregnant and pulmonary hypertension was premature.

Parents with babies born with these types of heart problems after use of Zoloft have blames the drug and it’s manufacturer Pfizer and they have filed lawsuits against Pfizer alleging its drug caused birth defects and accusing Pfizer of negligence and fraud.

The FDA currently does not have a definitive stance regarding SSRI medications and so women are left to determine the risks of using the drugs or having untreated depression while pregnant.

Medicaid Brand-Name Drugs When Prescribed Class Action Suit

There has been a settlement in a class-action lawsuit that will guarantee Medicaid beneficiaries to continue purchasing prescription drugs at a minimal cost when they become eligible for Medicare. The class action lawsuit, filed in 2007 by the Center of Medicare Advocacy and the National Senior Citizens Law Center in the United States District Court in San Francisco, on behalf of the 6.2 million Medicaid beneficiaries who alleged they were overcharged for drugs or even turned away from pharmacies due to processing delays of Medicare enrollment.

Medicare law states that people enrolled in both Medicaid and Medicare are to receive any assistance with purchasing prescription drugs and the beneficiaries who are eligible, will only have a co-pay as low as $1.05 to $3.10 for brand-name drugs. But, it was alleged that the beneficiaries were charged as much as $35 to $75 dollars. Evidence shows that their low-income status was not properly shared by government agencies, pharmacies and insurers.

The attorney for the plaintiffs in the class action lawsuit, claim that the delays have shortened since the Medicare prescription drug benefit took effect back in 2006. But, the average wait time currently is five to six weeks before tens of thousands of Medicaid beneficiaries who transfer to Medicare every month can begin receiving prescription drug benefits.

The settlement will make the Government change its computer system, which will allow states to submit names of new low-income Medicare beneficiaries more than once a month. Government officials will be required to process the submissions within one day. Insurers that deliver drug benefits, must also provide drugs at a minimal costs of all low-income Medicare beneficiaries who have qualified for additional assistance. Plus, if a beneficiary claims eligibility, but doesn’t have the proper documentation, or is soon to run out of medication, federal officials are required to immediately contact the state Medicaid agency to confirm their eligibility.

The settlement agreement is a great win for many of the United States most vulnerable citizens who face life-threatening delays in obtaining vital medications. Because of the class action lawsuit, it is now easier for the poorest beneficiaries to navigate Medicare Part D.

How to File a Class Action Suit on Vytorin

Class action lawsuits are a common aspect of dealing with faulty products and damages and/or losses suffered due to a company’s negligence. Meanwhile, understanding how they work and how one goes about filing them is another matter and is sometimes confusing to those who wish to file them. This is one of the reasons that it is recommended that you find an attorney who specializes in these types of claims before attempting to file it yourself. As with any other legal suit the aid of a lawyer can make all the difference between a successful outcome or the failure of the suit.

The basic steps of initiating a class action law suit are similar regardless of the company that is being sued. The first thing you want to do is find a lawyer, and then you will file the suit and notify all other plaintiffs by publication in a newspaper or by direct communication. Following this is supplying a notice to the court and parties on both sides that it has been filed. These are the general steps in initiating a class action suit and this is relevant to a suit that has not already been started. Joining in as a plaintiff on an already existing suit is another matter and does not require you to go through these early stages.

So, in a case such as the class action lawsuit against Vytorin, which is a pharmaceutical drug, where a suit has already been filed, how does one join in on the complaint? This suit was actually filed against the manufacturing pharmaceutical company Merck/Schering-Plough who recently agreed to pay out 41.5 million dollars. The suit claimed that the drug was misrepresented as being more affective at cholesterol reduction than the generic. Generally, the entire list of those who have been affected by the negligence are already included in the suit, but what happens if you’re not? There are a few different ways to find out the status of the suit and the easiest one is to contact the law firm that is handling the case and request to be included in it.

Zyprexa

Zyprexa

Class Action Lawsuit filed against Eli Lilly for failure to disclose risks to consumers

Products- Zyprexa

Drugs used for the treatment of psychological problems

Unintended Side Effect

Risks to patients with diabetes

Plaintiffs

People with diabetes and families of people with diabetes

History

Zyprexa was linked to serious side effects during May of 2002. It is Eli Lilly’s best selling drug and attorneys claim that the manufacturer failed to advise patients of the possible side effects and did not advise diabetes patients to monitor their blood sugar thereby causing injury and death.

Who Qualifies for a Class Action Claim?

People suffering from the following conditions and have taken the drug. The conditions include: diabetes mellitus, type 2 diabeties, pancreatitis, hyperglycemia, diabetic ketoacidosis ( DKA ), Neuroleptic Malignant Syndrome ( NMS ), diabetic coma caused by severe insulin deficiency.

Victims and their families have a right to take part in the class action suit. If you believe there has been harmed caused you may be entitled to compensation. Class action lawsuits are brought about to protect the public from corporate wrong doings.

Zicam

Zicam is an ‘over the counter’ homeopathic cold remedy nasal spray manufactured by Matrixx Initiatives, Inc. It comes in the form of a spray or swab and claims to reduce the time and symptoms of the common cold. Since its introduction it achieved high levels of success.

The active ingredient of Zicam is Zinc Gluconate. It has been claimed that Zicam has caused loss or distortion of the sense of smell and taste of patients using it. The loss of these senses greatly inhibits the lifestyle of individuals afflicted by these symptoms. The loss of sense of smell is known as anosmia. During February of 2004 reports started appearing indication that users of Zicam were suffering from anosmia.

It has been claimed that the public should have been made aware of the potentially dangerous side effects associated with the use of nasal products containing zinc, as well as the application of warning labels on the product. Medical researchers have for many decades associated the use of zinc based products with nerve damage. Zicam products, containing soluble zinc, were not tested by the FDA. An inquiry into this was sub sequentially made by the FDA .Matrixx claimed to be unaware of the FDA inquiry into the safety of Zicam and its possible side effects. Since then class action lawsuits have been filed by users of Zicam against both Matrixx Initiatives and Zicam LLC.

Vioxx

Vioxx (Rofecoxib) is a drug used to relieve osteoarthritis, rheumatoid arthritis as well as acute pain and menstrual symptoms.

Since its introduction in 1999 people around the world have been prescribed Vioxx for these types of medical problems. In the US there have been over 90 million users of the drug.

There is concern that the regular use of Vioxx causes some serious side effects including problems related to kidney and cardiovascular health, and the increased risk of heart attack and stroke.

On September 30, 2004 the manufacturer of the drug Merck has voluntarily recalled Vioxx. However litigation and class actions are being brought about regarding complications detailed in a FDA approved study relating to the severe side effects including increased chances of heart attack and stroke.

Symptoms of heart attack include chest pain, shortness of breath, impaired thinking, rapid heart beat, loss of appetite, edema and fatigue. Symptoms of stroke include numbness to one side of the body, vision impairment, dizziness, and trouble speaking or problems with motor skills.

 

News 8/18/2006

A New Orleans jury on Thursday ruled against Merck & Co. in the latest trial concerning embattled pain killer Vioxx, ordering the company to pay $51 million to a man who blamed his heart attack on the drug.

The jury ruled that the Whitehouse Station, N.J., pharmaceutical maker, which is building a $300 million plant in Durham, failed to provide ample warning to physicians about risks associated with the drug, according to reports from a number of media outlets covering the trial in Louisiana.

The company must now pay $50 million to compensate 62-year-old Gerald Barnett, 62, a former FBI agent, for a heart attack that he says was caused by Vioxx. The jury also awarded $1 million in punitive damages.

More than 16,000 lawsuits have been filed against Merck regarding Vioxx.

Merck has now lost four cases concerning Vioxx – one each in Louisiana and New Jersey and two in Texas. It has won one federal case and four state cases in New Jersey and California.

Vioxx was pulled from the market last year after studies found long-term use of the drug increased a patient’s risk for heart attack or stroke.

Merck (NYSE: MRK) has been promisted $40 million in state incentives to build a 250,000-square-foot vaccine plant in Durham that would create 200 jobs. The company has said the facility is on track for completion in 2007 or 2008.

Tequin

Tequin (gatifloxacin) is a quinolone antibiotic drug manufactured by Bristol-Myers Squibb.

Tequin is used to treat patients with bronchitis, pneumonia, sinus, respiratory tract, urinary tract infections, skin infections, kidney infections and sexually transmitted diseases

The use of Tequin has been associated in the risk of blood sugar abnormalities (Dysglycemia). These abnormalities are not restricted to patients with diabetes. Studies indicated a 4 times increased risk of Hypoglycemia (low blood sugar levels) and a 17 times greater risk of developing Hyperglycemia (high blood sugar). These abnormalities are brought about by the drug interfering with the regulation of insulin secretion from the pancreas. Other side effects include kidney failure, heart attack, stroke and seizure.

In lawsuits against Bristol-Myers Squibb it has been alleged that they failed to warn physicians and patients of risks associated with using the antibiotic. Risks associated with Tequin first came to public prominence in 2003 which resulted in some hospitals pulling the drug. In February 16, 2006 Bristol-Myers Squibb notified the FDA of proposed changes to prescribing information and a letter to doctors helping to identify blood sugar risk. On April 27, 2006 Tequin was withdrawn from the market.

On March 1, 2006 The New England Journal of Medicine (NEJM) posted on its web site an editorial about Tequin which called for, at least, the addition of a black box warning on the Tequin label, or package insert, and suggested further that an FDA recall of Tequin is warranted.

This March 2006 NEJM editorial, written by Dr. Jerry Gurwitz, of the Meyers Primary Care Institute in Worcester, Massachusetts, was prompted by two recent Canadian studies concerning the antibiotic Tequin (gatifloxacin) which indicate that this antibiotic can have life threatening side effects including hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar). The results of those Canadian studies were so alarming that the lead researcher is now urging doctors to stop prescribing Tequin, which is made by Bristol-Myers Squibb Co.

Regarding the issue of whether or not Tequin should be recalled, Dr. Gurwitz said that when the increased risk of adverse side effects from Tequin is compared to those of other drugs that have been pulled from the U.S. market in recent years, it seems that “this choice should not be a difficult one for physicians, patients, regulators and manufacturers.” In support of the idea that Tequin be pulled from the market, Dr. Gurwitz said, “For every approved indication for [Tequin], there are safer, equally effective and less costly alternatives.”

The cause for alarm about Tequin is the March 2006 NEJM article about two Canadian studies involving Tequin where researchers looked at health records for 1.4 million Ontario residents over age 65. Among that group were 17,000 patients who used Tequin. The researchers found that elderly patients who took Tequin were almost 17 times more likely to develop hyperglycemia (high blood sugar) than if they took another antibiotic. The researchers also reported that older patients were four times more likely to be hospitalized for hypoglycemia (low blood sugar). Both of these abnormal blood sugar, or glucose, conditions can be fatal if not treated promptly.

The extent and severity of these Tequin side effects prompted The New England Journal of Medicine to make the Tequin article — as well as the related editorial by Dr. Gurwitz — available online a month in advance of its scheduled March 30, 2006 publication date.

In mid-February 2006, the FDA and Health Canada issued warnings regarding Tequin. Each emphasized that Bristol-Myers Squibb was now telling doctors not to prescribe Tequin for patients with diabetics, and that the elderly and those patients with kidney problems are especially susceptible to serious side effects from Tequin use. The drug company said, also, that a labeling change for Tequin would include stronger warnings about the blood-sugar problems linked to Tequin.

Dr. David Juurlink, the lead researcher in the two Canadian studies and a physician at Sunnybrook and Women’s College Health Sciences Center in Toronto, clearly did not think stronger warnings on the Tequin label, or package insert, was enough. Rather, given the alarming results of his studies, Dr. Juurlink is urging doctors to no longer prescribe Tequin. Dr. Juurlink points out, “There are multiple alternatives that are just as good and do not have this set of side effects that is unpredictable and potentially life threatening.”

In interviews concerning the NEJM article about the Canadian studies invloving Tequin, Dr. Juurlink has warned that the blood-sugar problem “can happen to anybody” whether they have diabetes or not, and it “typically appears within a day or two of taking the drug.” Furthermore, Dr. Juurlink has commmented that the actual risk posed by Tequin is probably greater than his studies revealed, for this simple reason: “We can’t identify everybody, only those who survived [a seizure from low blood sugar and made it] to the hospital or those sick enough to go to the hospital.”

Following the early release of the NEJM article and editorial about Tequin, Bristol-Myers Squibb spokesman Eric Miller told reporters that the drug company has decided to stop actively marketing Tequin in the U.S.

Teflon

A $5 Billion class action lawsuit is being organized in Ohio and fourteen other states by owners of Teflon coated pots and pans. The lawsuit will be filed against DuPont and claims that they failed to disclose health risks associated with Teflon.

Teflon has been used to coat pots and pans since it was developed 40 years ago. The lawsuit claims that since the DuPont informed the government and consumers that Teflon was safe and that DuPont’s testing had shown the properties could become toxic after heating.

Lawyers for DuPont are claiming safe use throughout the materials 40 years of existence and that there are no studies exist reporting otherwise.

Attorneys for the plaintiffs will attempt to prove that DuPont failed to notify the public of potential health risks.

Seroquel

Seroquel

Class Action Lawsuit filed against AstraZeneca for failure to disclose risks to consumers

Product- Seroquel

Drugs used for the treatment of psychological problems

Unintended Side Effect

Risks to patients with diabetes caused by elevated blood sugar

Plaintiffs

People with diabetes and families of people with diabetes

History

Seroquel was linked to serious side effects during August of 2003. The FDA ordered a change in the label to identify the risks associated with diabetes. The manufacturer AstraZeneca failed to comply with this request.

Who Qualifies for a Class Action Claim?

People suffering from the following conditions and have taken the drug. The conditions include: diabetes mellitus, type 2 diabeties, pancreatitis, hyperglycemia, diabetic ketoacidosis ( DKA ), Neuroleptic Malignant Syndrome ( NMS ), diabetic coma caused by severe insulin deficiency.

Victims and their families have a right to take part in the class action suit. If you believe there has been harmed caused you may be entitled to compensation. Class action lawsuits are brought about to protect the public from corporate wrong doings.

Article

The FDA approved the drug Seroquel in 1997 for the treatment of schizophrenia and bipolar mania. Schizophrenia is not a multiple personality disorder, as it is commonly portrayed by the media, but rather a mental disease that causes people to fail to perceive reality properly. Schizophrenia can cause hallucinations, delusions and disorganized thinking processes. Bipolar mania is a mood disorder that is characterized as having extreme emotions. Usually these extreme emotions involve hyperactivity, increased sexual desires, increased irritability and sometimes euphoria.

Recently this drug has been linked to potentially fatal conditions such as diabetes and pancreatitis. If these conditions are left unchecked, they can sometimes lead to catastrophic problems such as ketoacidosis, coma and potentially death.

Seroquel is also known to cause an increase in appetite which ultimately causes the patient to gain weight. Weight gain can be an early sign of diabetes, hyperglycemia or other dangerous conditions. Unfortunately, Seroquel users have found it difficult (if not impossible) to lose the weight after it’s been put on after using the drug.

If you or a loved one has been faced with the devastating side effects of the drug Seroquel, it’s very important that you have someone to turn to for help. Seroquel induced diabetes or pancreatitis victims DO have legal rights. A qualified defective drug attorney can help you receive compensation for your injuries and fight for your rights. It’s time drug makers like AstraZeneca are held accountable for their actions. Please contact an attorney as soon as possible.

Orth Evra

When the Food and Drug Administration approved the Ortho Evra Transdermal Birth Control Patch in November 2001, it became the first transdermal patch to effectively deliver a combination of norelgestromin and ethinyl estradiol, two vital hormones that help prevent unwanted pregnancy. The “patch” as it was called, was a revolution in birth control because it allegedly provided the same amount of security against accidental pregnancy in an easier to take format. One large advantage of the Ortho Evra patch, according to its manufacturer Ortho-McNeil, lies in the once weekly application to the skin on the thighs, hips, or upper body rather than a daily pill. The patch is replaced every week in a month except the fourth, which allows a woman to have a menstrual period as normal.

Unfortunately, the high concentrations of the norelgestromin and ethinyl estradiol hormones cause severe and even fatal side effects in some women. Birth control pills have been known to cause blood clots, heart attacks, and strokes in some women, and smoking is also known exacerbate these risks. While many experts believed that there would be similar risks in a transdermal patch, they did not expect the significant increase in fatalities caused by the Ortho Evra patch.

The first fatality linked to Ortho Evra was an 18 year old fashion student in New York who collapsed and died due to a blood clot that traveled into her lungs. This terrible incident was merely the first of many deaths of women of all ages due to the tragic side effects of Ortho Evra. The Associated Press published a report on July 17, 2005 that the chances of suffering a non-fatal blood clot with the birth control pill was approximately 1 and 3 in 10,000, while the risk of dying was 1 in 200,000. The rates for the Ortho Evra patch indicated that non-fatal blood clots occurred 12 out of 10,000 times, while the death rate from these blood clots was 3 out of 200,000. Doctors later confirmed that the Ortho Evra patch increased the likelihood of fatal cardiac-related events by 300%.

Between April 2002 and December 2004, Ortho-McNeil received over 500 reports of incidents related to side effects and cardiovascular problems because of the Ortho Evra Patch. In the same time period, manufacturers of traditional birth control pills received only 61 such complaints. Data also showed that women who used the patch suffered four times as many strokes compared to those who did not. Furthermore, the FDA believes that they only receive between 1 and 10% of the reports of serious reactions, so most experts believe that the fatality rate of the Ortho Evra patch could be even higher than estimated.

Mannatech

There are basically four major components, or essential molecular components that the body requires for what we call good health.

We know about amino acids and proteins, that’s category one. We know about fatty acids and nucleic acids, that’s category two. We know about vitamins and minerals and trace elements that are required, that’s three. And then we’ve always known about carbohydrates, whether its rice, potatoes, corn, wheat, whatever – that you eat it, as category four. We’ve always known that those are the four necessary components for the human body.

Carbohydrates are consumed and broken down into simple sugars and then burned up at a cellular level as fuel, or gasoline. So this one category has always been known for the fuel side, for energy. And then the other three have always been known as critical for how the body functions.

What Mannatech found is that the carbohydrate chain is not just some interesting molecules that are used as fuel. They researched and discovered that there are some unique molecules, eight of them, which they actually physically isolated, that are used as building blocks or raw materials. These eight molecules are known as monosaccarhides or glyconutrients.

Let’s say these glyconutrients are Legos. One of them is a red six dot Lego, one of them is a black two dot Lego, one of them is a white narrow, single strip flat Lego and so forth. All eight of these little Lego pieces somehow, in the body’s synthesis and physiological process, multiply and combine and build configurations that build the phone lines, or communication mechanism, that allows one cell to talk to another cell.

In other words, we have trillions of cells in our body and cells need to properly communicate to one another. They need to be able to ask each other questions such as: are you friendly, are you an enemy, how does this affect my organ, how does this affect this system or that system? This communication process helps them to ultimately determine whether the cells are properly functioning. Mannatech found out that these phone lines, or glyconutritional components, were used to allow these cells to communicate at a cellular level.

Unfortunately we might be deficient in these essential glyconutrients so the phone lines can’t be properly built. This is due to things such as green harvests, processing, preservatives, increased toxins, limited variety of grocery store foods we eat, and gradual soil depletion. The key here is that what was once able to convert from one molecule to another may have been interfered with because of contaminates, the environment, and everything else around us.

So you have this very critical group of plant based molecules that the body has to have so it can build phone lines, so that cells can communicate. If the cells communicate properly then the tissues function, the organs function, and the systems of the body function. If that’s ever violated, or if those components are not put into the body, or the body is adversely affected because of environmental and diet issues and all the things that are around us in the 21st century, then those phone systems and those molecules can’t built.

Now, all of a sudden, you have a body and a group of systems that aren’t properly communicating. They are malfunctioning and misunderstanding each other. This miscommunication can take years for the physical signs to manifest and become recognizable. This miscommunication is why the body then isn’t able to heal itself, isn’t able to repair itself, or it blatantly malfunctions and miscommunicates on itself and causes an autoimmune disease.

Mannatech took these isolated molecules and created a glyconutritional blend consisting of all eight of the monosaccharides. This nutraceutical supplement is known as Ambrotose Complex. It gives the body the glyconutrients it is missing so that the body can turn around and create the phone lines necessary to have proper cell-to-cell communication.

Fosamax and Bisphosphonates

 

Fosamax is a drug that helps reverse bone loss and bone thinning and prevents the onslaught of osteoporosis. Fosamax is also know as a bisphosphonate.

Over 10 million people suffer from osteoporosis, with over 34 million suffering from low bone mass. It is a difficult disease to self diagnose with a bone density test being used to determine it existence.

Fosamax and other stronger forms of bisphosphonates are often used to manage advanced cancers that have metastasized to the bone. In these cases the bisphosphonates are usually given intravenously for longer time periods.

Fosamax (alendronate sodium) is an aminobisphosphonate that acts as a specific inhibitor of osteoclast-mediated bone resorption. Bisphosphonates are synthetic analogs of pyrophosphate that bind to the hydroxyapatite found in bone.

Severe side effects have been linked to the use of bisphosphonates including Fosamax. These include osteonecrosis of the jaw (ONJ or ‘dead jaw’). Osteonecrosis of the jaw is a rare but serious condition that involves the loss, or breakdown, of the jaw bone. Symptoms include gum problems, loose teeth and heaviness of the jaw. The diagnosis of osteonecrosis is done by x-rays and microbial cultures. Treatments include antibiotics, rinses and removable mouth appliances.

Litigation and class actions are being brought about regarding complications from bisphosphonate relating to osteonecrosis of the jaw and other serve side effects.

Article

Fosamax is a medication created to help osteoporosis, a bone disease which generally affects postmenopausal women in the United States. Fosamax is used by both men and women to treat the disease. It can be taken orally in either a pill or fluid format, and is generally consumed on an empty stomach.

The drug is used in aid of rebuilding and fortifying weak bones so that the person can avoid debilitating and harmful fractures of the bones. This little tablet helps control Paget’s disease and osteoporosis, but unfortunately it cannot prevent or cure them.

It’s unfortunate, but medication like Fosamax can cause serious complications for its users. Just like other osteoporosis dugs, Fosamax will cause severe gastrointestinal problems such as nausea and constipation. In rare instances, Fosamax can even result in Osteonecrosis of the jaw (or ‘dead jaw’) and harm one’s ability to eat, swallow and speak.

The pharmaceutical industry has developed and marketed numerous amounts of medications to prevent and treat these conditions, but unfortunately all of these drugs have severe side effects. Because the medications alter basic bodily functions so dramatically, the consequences of taking these medications can be sometimes be awful. Additional side effects can often include sleeplessness, nausea and fatigue.

If you or a loved one has been harmed by the use of osteoporosis medication such as Fosamax then you have the right to seek compensation for your injuries. It’s important that you call an experienced and knowledgeable osteoporosis drug attorney today.

Lariam

Mefloquine is an anti-malarial drug marketed under the name Lariam. Doctors are still unsure exactly how Mefloquine protects a patient from malaria, but it is generally theorized that it prevents the malaria parasite from breaking down a substance in the blood called haemin by making the haemin toxic to the parasite. However it works, it is the most effective anti-malarial drug on the market, especially in areas where the malaria parasite has grown resistant to more conventional malaria drugs. At first it was believed that mefloquine (Lariam) had a low incidence of side effects, but it turns out that only a fraction of the problems with mefloquine had been made public. As more travelers come out to tell horror stories of Lariam experiences, controversy rises about the pros and cons of taking mefloquine.

Malaria is a serious, sometimes deadly, parasitic infection that is transmitted through mosquito bites in many tropical regions of the world. Mefloquine, or Lariam, is the most often prescribed preventative for the disease. It is very effective at preventing the disease and is usually safe to take, but the adverse reactions that do occur are debilitating and possibly fatal. Forty-six people in Britain have already filed suits against the drug’s manufacturer, Hoffmann-La Roche. Another 150 are in the process of doing so and more than 500 more have contacted lawyers leading to action. In America, the first Lariam lawsuit was filed by a 25 year-old Californian man who claims to have suffered crippling Lariam side effects for nearly 3 years.

The Yellow Card scheme, a system through which doctors abroad file concerns with the Committee on Safety of Medicines, reported 1505 adverse reactions to mefloquine between 1990 and 1998. Five of these cases resulted in death. This seems like a very small number until one considers the results of a 1996 survey finding that only 10.15% of suspected adverse mefloquine reactions are reported. The true incidence of negative side effects could be much higher.

So what are these side effects? Serious side effects to mefloquine include dizziness, depression, psychosis, epileptic seizures, fits, suicide, and Stevens Johnson Syndrome (SJS). SJS is a rare but often fatal skin disease. A 7 year-old girl died of Stevens Johnson Syndrome just this year after taking Lariam for a family vacation. According to its own internal documents, Roche pharmaceuticals has received over 3,000 reports of psychiatric problems associated with Lariam, from nightmares, depression, hallucinations, to paranoia, psychosis, and aggression. Lariam was also a suspected part of the Fort Bragg murders in 1992, when four army officers on leave from Afghanistan (where they were prescribed Lariam) killed their wives on an army base in South Carolina. Two of the officers then killed themselves.

Roche Pharmaceuticals insists that only one in 10,000 patients suffer debilitating side effects from taking Lariam, but a British survey found that the number is closer to one in 140. It turns out that Roche defined a debilitating side effect as one that resulted in death. In fact, it can take years for the serious side effects, such as seizures and psychotic paranoia, to wear off. Hundreds of people return from vacations only to be committed to asylums or sit at home collecting disability checks.

Part of the reason that Lariam is still so widely used is that only about 10% of those suffering from Lariam side effects have spoken up. If you or someone you love has taken Lariam and experienced any of this, contact a lawyer immediately and discuss your options. Though Roche Pharmaceuticals has improved the warnings on its packaging, it still does not own up to the worst of Lariam’s side effects, and for many years the drug was marketed without serious warnings at all.

Enbrel

 

Class Action Lawsuit filed against Immunex Corporation for failure to disclose risks to consumers and advise patients to monitor infection levels causing unnecessary deaths and injury.

Product- Enbrel

Drug used for the treatment of rheumatoid arthritis and psoriatic arthritis

Unintended Side Effect

Unintended side effects include serious infections and other serious blood disorders as well as nervous system disorders such as multiple sclerosis and seizures.

People with rheumatoid arthritis and psoriatic arthritis and families of people with rheumatoid arthritis and psoriatic arthritis

History

Enbrel has been linked to serious side effects. The drug works by weakening the body’s immune response and reducing inflammation which plays a major factor in rheumatoid and psoriatic arthritis. Because the drug weakens the immune systems it can cause other serious side effects including sepsis which is a severe blood infection.

Who Qualifies for a Class Action Claim?

People suffering from the following conditions and who have taken the drug. The conditions include: serious infections, sepsis and other serious blood infections, and serious nervous system disorders such as multiple sclerosis and seizures.

Victims and their families have a right to take part in the class action suit. If you believe there has been harmed caused you may be entitled to compensation. Class action lawsuits are brought about to protect the public from corporate wrong doings.

Celebrex

Celebrex is an anti-inflammatory and painkilling drug made by Pfizer and used to treat conditions such as arthritis. It has been reported that the drug has greatly increased patients risk of developing cardiovascular disease including myocardial infarction (heart attack) or stroke. It has been claimed that Pfizer knew of this risk but continued to market and sell the product claiming that it was safe for use. Therefore it has been claimed that Pfizer knowingly put patients at risk by stating that the side effects encountered by some patients should not prevent other patients from benefiting from the drug. At the end of 2004 the first class action lawsuit was filed in Illinois.

 

Bad Behavior has blocked 443 access attempts in the last 7 days.